Internal Medicine, Endocrinology, Diabetes, & Metabolism · Omaha, NE
NPI
1124057559
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7831 Chicago Court
Omaha, NE, 68114
Phone (402) 561-2740
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
19,504 services
Medicare patients, 2024
598
Average age 73
Drug cost, 2024
$2.7M
7,844 prescriptions
Company payments, 2025
$903
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Claire Baker was code 99214 (office e&m - established), 675 times for 400 patients. In total Claire Baker billed 19,504 services in 35 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 675 | 400 | $81.76 | $55K |
| 36415 Venipuncture Blood Collection | Office | 599 | 425 | $8.52 | $5,106 |
| 83036 Blood Count | Office | 545 | 314 | $9.44 | $5,145 |
| 95251 Test - Miscellaneous | Office | 316 | 175 | $22.82 | $7,211 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 264 | 220 | $11.66 | $3,078 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 127 | 51 | $32.51 | $4,129 |
| 85027 Blood Count | Office | 98 | 98 | $6.34 | $621 |
| 99204 Office E&M - New | Office | 80 | 80 | $105.14 | $8,411 |
| 96372 Injection Administration | Office | 79 | 16 | $9.55 | $754 |
| 82570 Clinical Chemistry | Office | 69 | 69 | $5.03 | $347 |
| 82043 Clinical Chemistry | Office | 69 | 69 | $5.60 | $387 |
| G0008 Administration of influenza virus vaccine | Office | 48 | 48 | $29.16 | $1,400 |
| 90662 Vaccine Product | Office | 44 | 44 | $79.96 | $3,518 |
| 99213 Office E&M - Established | Office | 43 | 43 | $49.86 | $2,144 |
| 82044 Clinical Chemistry | Office | 27 | 27 | $6.11 | $165 |
By year: 2022 $123K for 13,534 services; 2023 $137K for 15,254 services; 2024 $132K for 19,504 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 599 | 425 | $8.52 | $5,106 |
| 83036 Blood Count | 545 | 314 | $9.44 | $5,145 |
| 85027 Blood Count | 98 | 98 | $6.34 | $621 |
| 82043 Clinical Chemistry | 69 | 69 | $5.60 | $387 |
| 82570 Clinical Chemistry | 69 | 69 | $5.03 | $347 |
| 82044 Clinical Chemistry | 27 | 27 | $6.11 | $165 |
| 81003 Clinical Chemistry | 18 | 18 | $2.20 | $39.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Claire Baker prescribed most often to Medicare patients was Levothyroxine Sodium, with 805 prescriptions and refills. In total Claire Baker wrote 7,844 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 805 | 1,796 | 180 | $5,974 |
| Ozempic Semaglutide | 342 | 456 | 63 | $423K |
| Metformin Hcl Er Metformin Hcl | 312 | 866 | 95 | $3,551 |
| Trulicity Dulaglutide | 308 | 397 | 50 | $365K |
| Jardiance Empagliflozin | 305 | 544 | 63 | $305K |
| Synthroid Levothyroxine Sodium | 298 | 615 | 55 | $24K |
| Atorvastatin Calcium Generic | 284 | 613 | 64 | $2,184 |
| Metformin Hcl Generic | 280 | 660 | 63 | $2,051 |
| Glimepiride Generic | 262 | 739 | 72 | $1,855 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 253 | 536 | 62 | $34K |
| Tresiba Flextouch U-100 Insulin Degludec | 235 | 508 | 62 | $164K |
| Novolog Flexpen Insulin Aspart | 194 | 323 | 60 | $45K |
| Mounjaro Tirzepatide | 180 | 197 | 28 | $202K |
| Humalog Kwikpen U-100 Insulin Lispro | 177 | 329 | 57 | $40K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 163 | 338 | 52 | $19K |
Brand drugs: 4,005 claims; generic drugs: 3,159 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Claire Baker $903 ($903 in general payments such as food, travel and fees) from 25 companies. The largest payer was Medtronic, Inc. with $89.47.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 3 | $89.47 |
| Lilly USA, LLC LLY | 4 | $64.52 |
| Abbvie Inc. ABBV | 4 | $64.12 |
| Amgen Inc. AMGN | 4 | $63.56 |
| Radius Health, Inc. | 3 | $59.95 |
| Novo Nordisk Inc NVO | 3 | $58.49 |
| Soleno Therapeutics, Inc. SLNO | 3 | $56.18 |
| Abbott Laboratories ABT | 3 | $49.5 |
| Beta Bionics, Inc. BBNX | 4 | $48.72 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $46.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.